who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

Stryker Corporation (SYK) earnings date & Q3 2026 results

US GAAP · quarter ended 09/30/2026 · released Oct 29

Net earnings

$753M

down 12.3% y/y

Net sales

$6,520M

up 7.6% y/y

Operating income

$1,034M

down 8.9% y/y

Next report

~ Jan 28

not announced yet

The quarter in brief

Net sales rose 7.7% to $6,520 million, but net earnings fell 12.3% to $753 million and diluted EPS dropped 11.7% to $1.96. Operating income declined 8.9% to $1,034 million.

Key growth driver: SG&A grew 13.1% to $2,313 million, including $137 million of structural optimization and other special charges, of which $77 million related to the Spinal Implants sale. · by the Q3 2026 report

All figures in $M.

Sankey diagram of SYK (Stryker Corporation) earnings report for Q3 2026: revenue, costs and profitNet sales$6,520 · +7.6%Cost of sales$2,272 · +3.0%Gross profit$4,248 · +10.3%65.2% marginResearch,development andengineeringexpenses$433 · +5.6%Selling, generalandadministrativeexpenses$2,313 · +13.1%Amortization ofintangible assets$175 · −7.4%Goodwill andother impairments$293 · +301%Operating income$1,034 · −8.9%15.9% marginOther income(expense), net$37 · −65.1%Earnings beforeincome taxes$997 · −3.1%Income taxes$244 · +43.5%24.5% effective rateNet earnings$753 · −12.3%$1.96/sh · 11.5% margin
Sankey diagram of SYK (Stryker Corporation) earnings report for Q3 2026: revenue, costs and profit
Line itemAmount and change
Net sales$6,520 · +7.6%
Cost of sales$2,272 · +3.0%
Gross profit$4,248 · +10.3% · 65.2% margin
Research, development and engineering expenses$433 · +5.6%
Selling, general and administrative expenses$2,313 · +13.1%
Amortization of intangible assets$175 · −7.4%
Goodwill and other impairments$293 · +301%
Operating income$1,034 · −8.9% · 15.9% margin
Other income (expense), net$37 · −65.1%
Earnings before income taxes$997 · −3.1%
Income taxes$244 · +43.5% · 24.5% effective rate
Net earnings$753 · −12.3% · $1.96/sh · 11.5% margin

Verdict: Net sales rose 7.7% to $6,520 million, but net earnings fell 12.3% to $753 million and diluted EPS dropped 11.7% to $1.96. Operating income declined 8.9% to $1,034 million.

Stryker updated full-year 2026 guidance to organic net sales growth of 6.5% to 7.0% and adjusted EPS of $14.80 to $14.90. The company repurchased $1.0 billion of stock in the quarter, and in October 2026 the Board added $3.0 billion to the repurchase program. Dividends paid in the first nine months totaled $1,012 million versus $963 million a year earlier.

Source and notation

Source: Stryker press release, 8-K EX-99.1 of 10/29/2026 (SEC EDGAR).

Open as an image: Stryker Corporation (SYK), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “Stryker Corporation (SYK) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/syk. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/syk"><img src="https://whoreportstoday.com/t/syk/img/stryker-syk-earnings-sankey.png" alt="Stryker Corporation (SYK) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/syk">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/syk/img/stryker-syk-earnings-sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/syk">Stryker Corporation (SYK) Q3 2026 earnings chart (Who Reports Today)</a>

The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. · Text: Wikipedia, CC BY-SA 4.0, abridged

The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Heads-up

Company reports

Q3 2026latest breakdownNet sales rose 7.7% to $6,520 million, but net earnings fell 12.3% to $753 million and diluted EPS dropped 11.7% to…
Q2 2026A strong recovery quarter—9.4% sales growth and a 158M tariff-charge reversal drove operating margin up 670bps and net…

Company guidance

PeriodCompany guidanceA year agoImplied growth
FY2026revenue growth +7%EPS (non-GAAP) $14.80–14.90revenue $25.1BEPS (GAAP) $8.40—

Same quarter a year ago (ended December 31, 2025): revenue $7.17B, EPS (GAAP) $2.20

How we calculate

EPS growth is not calculated: the guidance is non-GAAP (adjusted), while the year-ago EPS is GAAP, so the two are not comparable.

Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.

Guidance comes from the company's earnings release (Form 8-K filed Oct 29, 2026); every figure is checked against the release text.

The company's release on SEC EDGAR (8-K exhibit) ↗

SYK earnings history: past report dates

Oct 29, 2026 Thu4:11 pmafter market closeSep 30, 2026$6.5B+8% y/y$1.96−12% y/y
Jul 30, 2026 Thu4:09 pmafter market closeJun 30, 2026$6.6B+9% y/y$3.30+44% y/y
Apr 30, 2026 Thu4:07 pmafter market closeMar 31, 2026$6.0B+3% y/y$1.93+14% y/y
Jan 29, 2026 Thu4:11 pmafter market closeDec 31, 2025$7.2B+11% y/y$2.20+56% y/y
Oct 30, 2025 Thu4:15 pmafter market closeSep 30, 2025$6.1B+10% y/y$2.22+3% y/y
Jul 31, 2025 Thu4:12 pmafter market closeJun 30, 2025$6.0B+11% y/y$2.29+7% y/y
May 1, 2025 Thu4:10 pmafter market closeMar 31, 2025$5.9B+12% y/y$1.69−18% y/y
Jan 28, 2025 Tue4:07 pmafter market closeDec 31, 2024$6.4B+11% y/y$1.41−53% y/y
Oct 29, 2024 Tue4:09 pmafter market closeSep 30, 2024$5.5B+12% y/y$2.16+20% y/y
Jul 30, 2024 Tue4:09 pmafter market closeJun 30, 2024$5.4B+9% y/y$2.14+11% y/y
Apr 30, 2024 Tue4:11 pmafter market closeMar 31, 2024$5.2B+10% y/y$2.05+33% y/y
Jan 30, 2024 Tue4:07 pmafter market closeDec 31, 2023$5.8B+12% y/y$2.98+103% y/y
Nov 2, 2023 Thu4:20 pmafter market closeSep 30, 2023$4.9B+10% y/y$1.80−16% y/y
Aug 3, 2023 Thu4:12 pmafter market closeJun 30, 2023$5.0B+11% y/y$1.93+12% y/y
May 1, 2023 Mon4:10 pmafter market closeMar 31, 2023$4.8B+12% y/y$1.54+83% y/y
Jan 31, 2023 Tue4:07 pmafter market closeDec 31, 2022$5.2B+11% y/y$1.47−15% y/y
Show all 16 reports since 2023Show fewer
How we count

Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.

Stryker Corporation: 15-year financials

202525,1164,8893,2464,2831,284
202422,5953,6892,9933,4871,219
202320,4983,8883,1653,1361,139
202218,4492,8412,3582,0361,051
202117,1082,5841,9942,738950
202014,3512,2231,5992,790863
201914,8842,7132,0831,542778
201813,6012,5373,5532,038703
201712,4442,2971,020961636
201611,3252,1751,6471,425568
20159,9461,8611,439711521
20149,6751,2465151,549462
20139,0211,2561,0061,691401
20128,6571,7411,2981,447324
20118,3071,6861,3451,208279

$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.

* Sources
How we calculate

Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.

Stryker Corporation: 15-year balance sheet

YearAssetsEquityDebtCashCurrent assetsCurrent liabilities
202547,84422,42015,8594,01114,7557,794
202442,97120,63413,5973,65214,8477,616
202339,91218,59312,9952,97112,5187,921
202236,88416,61613,0481,84410,2756,303
202134,63114,87712,4792,94410,0174,549
202034,33013,08413,9912,9439,7075,041
201930,16712,80711,0904,33711,0584,400
201827,22911,7309,8593,6169,7334,807
201722,1979,9667,2222,5427,9933,485
201620,4359,5507,1143,3167,8613,148
201516,2238,5113,9983,3797,9433,502
201417,2588,5953,9731,7958,6844,461
201315,3999,0472,7641,3398,3352,657
201213,2068,5971,7621,3958,1481,876
201112,1467,6832,2689057,2071,840

$ millions, at fiscal year-end*.

* Sources
How we calculate

Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .

Cash flow

9 months ended 2026-09-30 · $M

LineThis periodYear agoΔ
Operating cash flowcash the business generated3,3032,901+402
· incl. D&A (non-cash add-back)depreciation & amortization1,1961,153
· incl. stock-based comp (non-cash)share-based compensation208195
Capexpurchases of property & equipment−605−493−112
Free cash flow ≈operating cash flow − capex2,6982,408+290
Investing activities, netcapex, acquisitions, securities−1,011−4,561+3,550
· incl. acquisitionsbusinesses net of cash acquired−481−4,950+4,469
Financing activities, netdebt, buybacks, dividends−2,9981,206−4,204
· incl. buybacksrepurchases of common stock−1,0000−1,000
· incl. dividends paid−1,012−963−49
FX effect on cash−3458−92
Net change in cash−740−396−344
How to read the table

Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.

Shareholders’ equity at Sep 30, 2026: $23.5B (50% of total assets). Compare with other S&P 500 companies →

Corporate governance

2/2good

  • Feb 2026Cover of the 2025 10-K: one registered class of common stock — Common Stock, $.10 par value (NYSE: SYK). sec.gov ↗
  • Feb 2026Diluted weighted average shares +1.6% over 2020–2025; SBC $243M — 1.0% of $25.1B revenue. data.sec.gov ↗
2 more facts and scoring

How the company treats minority shareholders: 2 — well, 0 — systematically poorly.

  • Feb 2026Declared dividend: $2.585 (2021) → $2.835 → $3.05 → $3.24 → $3.40 per share (2025). sec.gov ↗
  • Feb 202610-K: in 2025 the SEC and DOJ notified the company they had closed their FCPA inquiries; no shareholder disclosure suits. sec.gov ↗

Scoring: 2.0 with no deductions = 2.0 (single share class, diluted shares +1.6% over 5 years, dividend raised every year, no shareholder lawsuits; SEC/DOJ FCPA inquiries closed in 2025)

Share classes
10-K cover: one class — Common Stock $.10 (NYSE: SYK) plus euro-denominated notes.
Dilution
Diluted shares +1.6% over 2020–2025; deals (Wright Medical, Inari and others) paid in cash; SBC 1% of revenue.
Disclosure
Full reporting, no violations.
Dividends
Declared dividend rising: $2.585 (2021) → $3.40 (2025).
Lawsuits & regulators
10-K: product liability (implants) and patent suits; the SEC and DOJ closed their FCPA inquiries in 2025 with no action; the 2013/2018 SEC FCPA cases are not deducted under the methodology; no shareholder lawsuits.
Related parties
No material related-party transactions.

How the score works · checked as of Oct 2026

Included in screener lists: S&P 500 companies that paid dividends 10 years without a gap

Stryker Corporation (SYK) earnings: FAQ

When is SYK's next earnings date?

We have not yet seen an announcement of the date from Stryker Corporation (SYK). Based on last year's report on Jan 29, 2026, the next report is expected around Jan 28, 2027.

What time does SYK report earnings?

Stryker Corporation usually reports after market close: its latest results release was filed with the SEC at 4:11 pm ET on Oct 29, 2026.

When did SYK last report earnings?

Stryker Corporation reported Q3 2026 results on Oct 29, 2026.

What has Stryker Corporation guided for FY2026?

Company guidance for FY2026: revenue growth +7%; EPS (non-GAAP) $14.80–14.90. A year ago (FY2025): revenue $25.1B, EPS (GAAP) $8.40. Source: the company's earnings release (Form 8-K filed Oct 29, 2026).

Where can I find Stryker Corporation's financial statements?

On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to SYK's filings; this page breaks the latest report down in a Sankey chart.

What was SYK's net income in Q3 2026?

Stryker Corporation reported net income of $753M for Q3 2026 (−12.3% year over year), under US GAAP.

Does Stryker Corporation pay dividends?

Yes. In 2025, Stryker Corporation paid $1,284M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.

How has Stryker Corporation's revenue changed since 2011?

Per its 10-K filings, revenue grew 3x: $8,307M in 2011 and $25,116M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.

New to earnings reports? Start with how to read an earnings report.

Get it every Monday: who reports this week

Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.

Only dates announced by companies. No stock prices. Not investment advice.

More reports: TECH · Q4 FY2026 · TMO · Q3 2026 · UHS · Q3 2026 · UNH · Q3 2026 · VEEV · Q2 FY2027 · VRTX · Q3 2026 · VTRS · Q2 2026 · WAT · Q3 2026 · WST · Q3 2026 · ZBH · Q3 2026 · all reports

Cookies the site needs and, with your consent, Google Analytics — privacy policy